Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-21-035008)

Filing Details

Accession Number:: 0001209191-21-035008
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-05-21 17:06:42
Reporting Period:: 2021-05-19

Accepted Time:: 2021-05-21 17:06:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1000694	Novavax Inc	NVAX	Biological Products, (No Disgnostic Substances) (2836)	222816046

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1589712	K. Rachel King	C/O Novavax, Inc. 21 Firstfield Road Gaithersburg MD 20878		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-05-19	700	$139.64	2,800	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,100	Indirect	See Footnote
Common Stock	1,100	Indirect	See Footnote

Footnotes

Represents shares attributable to the Reporting Person as indirect holdings held in a trust for the benefit of the Reporting Person's child.
Represents shares attributable to the Reporting Person as indirect holdings held in a trust for the benefit of the Reporting Person's child.